ABSTRACT Superoxide dismutase (SOD) and catalase (CAT), enzymes that degrade superoxide anion and hydrogen peroxide, respectively, reduce size of infarction in anesthetized, open-chest dogs subjected to coronary occlusion followed by reperfusion. To evaluate potential protective effects of these enzymes in conscious animals, three groups of dogs were instrumented at sterile surgery with a hydraulic occluder on the left circumflex (LCX) coronary artery, sonomicrometers to measure regional wall thickness, and catheters to monitor arterial and left ventricular pressures. Ten to 14 days after surgery, the animals were sedated with morphine sulfate (0.5 mg/kg). The LCX artery was occluded for 3 hr by inflation of the hydraulic cuff. Infusions of SOD (n = 7), CAT (n = 6), or saline (control group, n = 7) were begun 15 min before reperfusion and lasted for 45 min of reperfusion. The doses of SOD and CAT were 5 mg/kg, dissolved in 60 ml of saline, and infused at a rate of 1 ml/min. Myocardial blood flow was measured with tracer-labeled microspheres (15 gm diameter) before occlusion, after 5 to 10 min of occlusion, after 150 min of occlusion, and 5 to 10 min after reperfusion. Size of infarction was measured 24 hr later by dual-perfusion staining with Evans blue and triphenyl tetrazolium. Size of infarction (expressed as a percentage of area at risk) did not differ significantly among the three groups: control, 32 + 17% (mean ± SD); SOD, 38 + 17%; CAT, 27+ 17%. Hemodynamic parameters and myocardial blood flows (measured before infusion of any agents) were not significantly different among the three groups. Serum SOD levels in SOD-treated dogs were 19 ± 2 gg/ml at the onset of reperfusion and 29 ± 3 gg/ml at the end of the infusion. Blood assays collected after infusion showed a monoexponential decay of SOD levels with a half-life of 22 ± 6 min. We conclude that myocardial protection by SOD or CAT is model dependent. In conscious dogs subjected to 3 hr of coronary occlusion followed by reperfusion, SOD and CAT failed to alter size of infarction.
after infusion showed a monoexponential decay of SOD levels with a half-life of 22 ± 6 min. We conclude that myocardial protection by SOD or CAT is model dependent. In conscious dogs subjected to 3 hr of coronary occlusion followed by reperfusion, SOD and CAT failed to alter size of infarction. Circulation 73, No. 5, 1065-1076, 1986. CONSIDERABLE INTEREST has focused recently on reduction of myocardial reperfusion injury with enzymes that degrade oxygen radicals, which are highly reactive oxygen species that are toxic to biologic tissues. For example, Jolly et The dogs were assigned randomly and blindly to treatment or control groups on the day of the study. The treatment was superoxide dismutase (5 mg/kg; Orgotein, Diagnostic Data, Mountain View, CA) or catalase (5 mg/kg; Calbiochem-Behring, La Jolla, CA). Control recordings were obtained and an injection of microspheres was performed. The left circumflex artery was abruptly occluded by inflation of the hydraulic occluder. Occlusion was verified by cessation of coronary blood flow velocity, prompt elimination of systolic wall thickening, characteristic increases in heart rate, and/or ST segment changes on the electrocardiogram. Five to ten minutes after coronary occlusion, a second injection of microspheres was made to document the extent of reduction of blood flow. The occlusion was maintained for 3 hr. A third injection of microspheres was made at 2.5 hr of occlusion to document any shortterm changes in collateral blood flow to the ischemic area.
Fifteen minutes later (15 min before reperfusion), infusion of 60 ml of saline alone or saline containing superoxide dismutase or catalase was begun. The infusion was continued for 45 min after abrupt release of the coronary occluder. Lidocaine (50 mg iv) was administered 3 min before release of the occluder to minimize the likelihood of ventricular fibrillation. Reperfusion was verified by restoration of coronary blood flow velocity or observation of increases in end-diastolic wall thickness measured with the sonomicrometers. A fourth injection of microspheres was made 5 to 10 min after releasing the occluder to provide additional documentation that blood flow had been reestablished.
The femoral cutdown was repaired and the animals were returned to their cages 1 to 3 hr after reperfusion. The following day the dogs were returned to the laboratory, deeply anesthetized with sodium pentobarbital, and killed with intravenous KC]. Each heart was rapidly excised and prepared for quantification of infarct size in vitro.
Postmortem determination of infarct size. A dual perfusion technique was used to measure size of infarction as a percentage of the region at risk and of left ventricular mass. 1-3. 1 1-13 Cannulas were placed in the aorta above the coronary ostia and in the circumflex artery at the site of the occlusion. The circumflex bed was perfused with 1.5% triphenyl tetrazolium hydrochloride (TTC) in potassium phosphate buffer at a pressure of approximately 100 mm Hg. The aorta was perfused simultaneously with 0.5% Evans blue dye at the same pressure to delineate the nonischemic myocardium. The heart was then cut into eight sections (7 to 10 mm thick) perpendicular to the apical-basal axis. The myocardium perfused by the circumflex artery constituted the region at risk of infarction and it was identified by the presence of a red color (due to the dehydrogenase conversion of the TTC to a red formazan) and absence of blue dye. The infarcted area was apparent as tissue that lacked staining (due to loss of dehydrogenase activity in infarcted tissue) within the region at risk. 14 We recognize that simultaneous dye perfusion of both normal and ischemic myocardium at a pressure that exceeds perfusion pressure of the ischemic zone in vivo may overestimate the area at risk. There was good agreement, however, between the delineation of the ischemic zone by blood flow measurements and that by the dual perfusion dye technique, suggesting that the degree of error was small. Any error that was encountered should have been similar across all three groups in the present study because the same technique was used in each experiment. In addition, this technique provides data that can be compared directly with those of several other investigatorsl-3 11-13 who used similar methods. 15 Four injections were made in the experiments, with the use of one of six available isotopes ('41Ce, 5'Cr, HI3Sn, 103Ru, 95Nb, 46Sc) for each flow determination. The choice of isotopes was determined by which isotopes were available at the time, and the order of their injection was randomized. Approximately 1 to 2 million microspheres were injected into the left atrium for measurement of blood flows. The reference arterial sample was obtained from the catheter inserted through the femoral artery into the aorta at a constant rate (7.0 ml/min) with a Harvard withdrawal pump; withdrawal of samples was initiated before the injection of microspheres and completed 2 min later. Each bottle of microspheres was thoroughly mixed by vortex agitation before injection, and droplets of the microsphere suspension were periodically examined under a microscope to ensure that adequate dispersal was being achieved.
Two of the eight transverse rings of left ventricle (at approximately the midpapillary muscle level) were used for blood flow determinations after overlay tracings and photographs were obtained for quantification of size of infarction. Full-thickness sections were obtained from the central ischemic and control areas (at least 1 cm away from the boundary between areas delineated by TTC and Evans blue dyes). Each section of tissue was divided into three pieces of approximately equal thickness from the endocardial to epicardial surfaces. The location of each piece was recorded and then the tissue samples were weighed and placed in counting vials for assay of radioactivity in a Tracor (Model 1185) gamma scintillation counter. After correcting the counts in each tissue sample for background and overlapping counts with simultaneous equations, blood flow was calculated with the equation'5 Qm = (Cm x Qr)/Cr, where Qm = myocardial blood flow (ml/min); Cm = counts/min in tissue samples; Qr = withdrawal rate of the reference arterial sample (ml/min); Cr = counts/min in the reference arterial sample. Flow per gram of tissue was calculated by dividing flow by the weight of the appropriate sample. Background and overlap corrections and blood flow calculations were performed on an Apple Il Plus microcomputer.
Assay for serum levels superoxide dismutase. Venous blood samples (approximately 10 ml each) were withdrawn into heparinized syringes immediately before the infusion of superoxide dismutase was begun and at 15 min intervals thereafter for 180 min. An equivalent volume of 0.9% NaCl was injected to replace the volume taken by the blood sample. Samples were also taken from one dog that received catalase and from one dog that received plain saline. Each sample was immediately centrifuged and the serum was carefully aspirated and transferred into coded plastic tubes that were capped and frozen at -80°C. The serum samples were sent, on dry ice, to Diagnostic Data, Inc. (Mountain View, CA) for assay. The samples were thawed and well mixed; superoxide dismutase standards were prepared from Orgotein 163/60 (Diagnostic Data, Inc.) diluted in 5% control sheep serum (PelFreez 39425-1). Dog serum samples, undiluted or diluted 1:5, and superoxide dismutase standards were electrophoresed in Tris glycine (pH 8.5)-buffered agarose gels and stained for superoxide dismutase activity by a modification of the nitroblue tetrazolium/riboflavin method of Beauchamp and Fridovich. 16 Superoxide dismutase levels were estimated independently by four individuals by visual comparison with the superoxide dismutase bands of the standards. There was no detectable superoxide dismutase activity in samples from catalase-treated or control dogs.
Data analysis. Recordings were made during each experiment on an eight-channel Hewlett-Packard pressurized-ink recorder and on magnetic tape (Vetter, Model D) for subsequent analysis. Variables analyzed were heart rate, peak left ventricular systolic pressure, left ventricular end-diastolic pressure, peak positive and negative dP/dt, mean arterial blood pressure, pressure-rate product (heart rate x peak systolic blood pressure), regional systolic wall thickening, and myocardial blood flow in control and ischemic areas. Data were analyzed at the four following times: (1) immediately before coronary occlusion (control conditions), (2) 10 min after circumflex occlusion, (3) 2.5 hr after occlusion (15 min before infusion of saline or one of the two enzymes), and (4) 5 to 10 min after release of the circumflex occluder.
A minimum of 10 cardiac cycles were averaged for each condition, with use of the beats occurring during the microsphere injections. The data were analyzed by digitizing the analog recordings on tape with the use of a DEC Micro PDP-1 1 microcomputer system. Analysis of variance was used to analyze differences within groups across the four time periods. '7 When a significant time effect was observed, paired t tests were used to determine which time periods differed from one another. Because multiple comparisons were performed, a Bonferroni correction of the acceptable p level was used.'7 Routinely six comparisons were performed so the conventional p value (.05) was divided by six to give p < .0083 as the minimum acceptable alpha level. When "p < .05" is indicated in the tables or text, this will refer to the "corrected value" actually corresponding to p < .0083. The Bonferroni adjustment was also applied to comparisons between the control, superoxide dismutase, and catalase groups (during each experimental condition) that were made with unpaired t tests. Data are presented in tables, text, and figures as mean + SD.
Results
A total of 29 dogs were studied, 20 of which are included in this report: seven in the control group, seven in the superoxide dismutase group, and six in the catalase group. Four dogs of the nine excluded died from ventricular fibrillation between 4 and 20 min after coronary occlusion. Five dogs demonstrated no regional dimensional or hemodynamic changes after coronary occlusion because of extensive native collaterals (confirmed by microsphere measurements of regional blood flow) and were also excluded. None of the 20 dogs included in the analysis had ventricular fibrillation and all survived the full 24 hr after coronary occlusion.
Hemodynamic parameters and regional wall thickening. Hemodynamic data are summarized in table 1 Data are mean ± SD. C = control group; SOD = superoxide dismutase group; CAT = catalase group; HR = heart rate. AFor difference between early and late occlusion and between occlusion and early reperfusion data (Bonferroni-adjusted paired t test).
Bp < .05; Cp < .01, for difference from control condition (Bonferroni-adjusted paired t test). There were no significant differences between C, SOD, and CAT groups during any condition.
ide dismutase, and catalase groups. The only significant hemodynamic changes after coronary occlusion were increases in heart rate and pressure-rate product ( (table 3) . Five to ten minutes after reperfusion, blood flow in the central ischemic area was restored to control levels and there were no significant differences among the three groups. Although reperfusion flows tended to exceed control condition averages, no statistically significant differences from control were detected (with the exception of midmyocardial blood flow in the superoxide dismutase group) given the high level of variability in these data. Part of the variability was likely related to the arrhythmias observed in most of the experiments. Because the reperfusion data were obtained during nonsteady-state conditions, we present it only to provide additional documentation that reperfusion occurred after release of the coronary occluder. Control zone blood flow was not significantly different compared with that at late occlusion ( region at risk, was 32.4 ± 16.5% in the control group, 38.4 ± 17.4% in the superoxide dismutase group, and 27.1 ± 16.6% in the catalase group. No significant differences were demonstrable, indicating that no myocardial protection (in the form of reduction of infarct size) was provided by superoxide dismutase or catalase in this study. Likewise, no significant differences were evident when size of infarction was expressed as a percentage of the left ventricle. The size of infarction measured in this manner in the control group averaged 14.6 ± 7.1% and that in the superoxide dismutase and catalase groups averaged 15.5 ± 6.9% and 13.3 ± 8.6%, respectively (figure 2).
Blood levels of superoxide dismutase. In figure 3 are shown superoxide dismutase levels at different times during and after its administration. There was relatively little variability between animals and blood levels were near their peak when the coronary occlusion was released, allowing reperfusion to occur. That peak levels were attained near the onset of the reperfusion phase is important because it is early during reperfusion that oxygen radical-mediated damage is conventionally thought to be maximal. The plasma half-life of superoxide dismutase in this conscious animal preparation was 22 ± 6 min (n = 7).
Analysis of variability of size of infarction. Because there were sizable standard deviations for the data on infarct size in our study, we evaluated the influence of size of the region at risk, pressure-rate product, and collateral blood flow on size of infarction.3 As shown in figure 4 , there was no relationship evident between size of the area at risk and infarct size (r = .32, p = NS), largely because the size of the risk regions were quite similar within and across groups. infarction ( figure 4) . Collateral blood flow, however, correlated with infarct size reasonably well (figure 5), especially the blood flow data obtained 2.5 hr after coronary occlusion. Although the collateral blood flow data could not account for all of the variability in size of infarction, we think collateral blood flow was the major contributing factor.
Discussion
Univalent reduction products of oxygen, some of which are free radicals, may contribute importantly to myocardial damage occurring with ischemia and reperfusion. These metabolites include superoxide anion The relationship between infarct size (IS) and collateral blood flow is presented for blood flow at 10 min after occlusion (EARLY) and that at 2.5 hr after occlusion (LATE). Data on infarct size are plotted vs blood flow to the subendocardium (ENDO) and subepicardium (EPI), as well as average (MEAN) blood flow across the wall. Regression lines (dashed) and correlation coefficients are superimposed on the graphs. Linear regression was adequate to describe the relationships for EARLY after occlusion but cubic (ENDO) and quadratic (EPI and MEAN) equations were necessary for the LATE data. Because significant correlations between collateral blood flow and infarct size were evident, but 11o significant correlations were demonstrable between infarct size and region at risk or pressure-rate product, we conclude that the primary reason for differences in infarct size was variability in collateral blood flow. -vw directly or to identify their sites of generation. Consequently, there is little definitive proof that they are involved in ischemic tissue damage. Nevertheless, indirect support for their involvement has been provided by studies showing reduction of global or regional ischemic or hypoxic damage" 2, 13, 18-24 by enzymes such as superoxide dismutase or catalase, which selectively degrade superoxide anion and hydrogen peroxide, respectively. Other chemicals, such as antioxidants, iron chelators, or inhibitors of enzymes thought to generate oxygen metabolites (e.g., allopurinol inhibition of xanthine oxidase), also reduce ischemic or hypoxic damage in ways that are less selective biochemically but are nevertheless consistent with inhibition of known pathways of oxygen metabolite formation or reactivity.
The effects of superoxide dismutase or catalase in the setting of experimental myocardial infarction were recently evaluated by Werns et al. 2 Reduction of infarct size of approximately 50% was achieved in anesthetized, open-chest dogs that were subjected to 90 min of left circumflex coronary occlusion followed by reperfusion. Superoxide dismutase was infused at the same dose (5 mg/kg) we used, beginning 15 min before release of coronary occlusion. The potential benefit of superoxide dismutase was clearly demonstrated in the study by Werns et al.,2 and insights were provided on the mechanism of oxygen radical-mediated damage during reperfusion. Considered with the reports of Romson et figure 2) . Therefore, the data demonstrate no protective effect of either superoxide dismutase or catalase after 3 hr of coronary occlusion followed by reperfusion in conscious dogs. The failure to show a reduction in infarct size with either of the two enzymes could not be attributed to differences among the groups with respect to hemodynamic parameters, severity of wall thickening dysfunction, level of collateral blood flow early or late in the occlusion period, or blood flow 5 to 10 min after reperfusion. There are several major differences between our study and that by Werns et al.2 that could account for our failure to show significant reductions in size of infarction. Because our animals were conscious during the study, we used morphine for ethical reasons and lidocaine just before reperfusion to reduce the incidence of lethal arrhythmias. Although either drug might confer intrinsic cardioprotection and mask potential beneficial effects of superoxide dismutase or catalase, both are used routinely in humans for their cardiac and extracardiac actions. Therefore, their use in this study does not constitute a major deviation from a human protocol. It is not known with certainty whether in dogs 90 min of regional ischemia,2 rather than 3 hr, produces ischemic damage that is more comparable to that occurring during clinically relevant ischemic periods in man. Related to this is the possibility that damage produced by 3 hr of ischemia is not amenable to reduction by drug intervention. The 3 hr ischemic period that we used, however, corresponds well to the shortest average times that patients are likely to Considerable variability was evident in the data on infarct size even though the regions at risk in vitro were very similar within and across groups (figure 2). Because hemodynamics were also quite similar, we think much of the variability was due to differences in collateral blood flow. Weak but statistically significant relationships existed between subendocardial, subepicardial, and mean transmural blood flow (in the central ischemic area) and size of infarction expressed as a percentage of the region at risk (figure 5). Although the catalase group was characterized by somewhat higher collateral flow than the other two groups, the data points from each group were distributed relatively uniformly, suggesting that variability in collateral flow was common to each experimental group. Unlike the AMPIM study group,3 we evaluated collateral blood flow in the subendocardium and transmurally (as well as in the subepicardium) early and late after coronary occlusion. Significant relationships were evident at both times, but there were substantial differences between the two. Consistent with the increases in collateral blood flow observed 2.5 hr after coronary occlusion (table 2), the regression lines were shifted rightward and they required nonlinear solutions. The data support the importance of early collateral blood flow as a determinant of ultimate size of infarction but also emphasize that later changes in collateral perfusion may occur in the acute infarction phase, contributing another potential source of variability.
Previous during the time of drug administration as a major source of oxygen radicals in our experimental preparation. Another possibility is that superoxide anion is not the major cytotoxic oxygen species in cardiac damage due to ischemia. Previous studies from our laboratories22 24 have failed to demonstrate protection by superoxide dismutase in experimental preparations in which other radical-related interventions, including catalase, have reduced damage. Since superoxide dismutase plus catalase reduces ischemic damage to blood-free isolated hearts,'9 endothelial or myocardial parenchymal cells may also act as significant sources of damaging oxygen metabolites via the action of xanthine oxidase,26 the mitochondrial electron transport chain, arachidonate metabolism, or other pathways. Both enzymes that we tested were accessible to the vascular face of the endothelium, and may have also gained access to the parenchymal side, so involvement of the endothelium as a source of oxygen metabolites is questionable in this preparation. An alternative explanation. therefore, is that the large mo-lecular weights of superoxide dismutase (32,000) and catalase (240,000) limited access to the sarcolemma, where they might degrade superoxide or hydrogen peroxide that diffuses from parenchymal cells, or access through the sarcolemma to the sarcoplasm, where they might degrade their substrates closer to intracellular sites of generation. The nature of our experimental preparation precludes determination of which, if any, of these possibilities is correct, and further investigation will be required to address these issues.
One interpretation of our data is that cytotoxic oxygen metabolites did not participate in the ischemic damage observed in our closed-chest model. Although we cannot conclusively reject this possibility, substantial evidence exists in the literature to implicate oxygen radicals in diverse preparations of cardiac ischemic or hypoxic damage. 2, 1824 In addition, coronary occlusion in closed-chest dogs rarely produces the total ischemia and complete anoxia that would be necessary to completely abolish oxygen metabolism. The data from our study show that ischemia was not complete since some collateral blood flow to the ischemic zone persisted (table 2) . This indicates that the tissue was not anoxic, but rather hypoxic. Therefore, an environment may have existed that was favorable for univalent oxygen reduction. There was substantial time (2.75 hr before drug intervention) for the development of damage by a free radical-mediated process that would not have been influenced by administration of superoxide dismutase or catalase much later. If this is correct, it incriminates oxygen radicals as contributors to myocardial damage in our preparation and emphasizes the need for early drug intervention. We propose that significant myocardial damage mediated by oxygen radicals can occur during a prolonged ischemic period, such as in our preparation, and is not necessarily restricted to the reperfusion phase (the focus of most experimental studies).
In deciding whether superoxide dismutase or catalase can effectively limit size of infarction, a key question to answer is which experimental preparation best simulates myocardial infarction in man. Unfortunately, an unequivocal answer to that question is not currently available. It is our conclusion that the effects (or lack of effects) of these enzymes on infarct size are strongly model dependent. An implication of this conclusion, in our view, is that the enzymes superoxide dismutase or catalase may prove useful only in selected circumstances and patients, which are yet to be adequately defined.
